Effects of glycosylated and non-glycosylated G-CSFs, alone and in combination with other cytokines, on the growth of human progenitor cells

Paolo Pedrazzoli, Nadia Gibelli, Lorenzo Pavesi, Pietro Preti, Marco Piolini, Francesco Bertolini, Gioacchino Robustelli Della Cuna

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Two recombinant human granulocyte colony-stimulating factors (rHu G-CSF) are clinically available, a glycosylated (lenograstim) and a nonglycosylated form (filgrastim). Since there is accumulating evidence that glycosylation plays a role in the vitro activity of the G-CSF molecule, we compared the biological potency of lenograstim and filgrastim on human hematopietic progenitor cells by colony assay in semisolid medium and ex vivo expansion experiments. Leukapheretic products without further processing and CD34-positive purified cells were used as source of human progenitors. Lenograstim demonstrated greater capacity, to stimulate the colony growth of both, purified and CD34+ peripheral blood cells. This effects, which is evident especially at low doses of growth factor, seems not to be mediated by accessory cells. Whether these observations may have clinical relevance is still to be clearly assessed and further investigations are needed.

Original languageEnglish
Pages (from-to)1781-1785
Number of pages5
JournalAnticancer Research
Volume16
Issue number4 A
Publication statusPublished - Jul 1996

Fingerprint

Granulocyte Colony-Stimulating Factor
Stem Cells
Cytokines
Growth
Glycosylation
Blood Cells
Intercellular Signaling Peptides and Proteins
lenograstim
Filgrastim

Keywords

  • Hematopoietic progenitor cells
  • Recombinant human G-CSF

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Effects of glycosylated and non-glycosylated G-CSFs, alone and in combination with other cytokines, on the growth of human progenitor cells. / Pedrazzoli, Paolo; Gibelli, Nadia; Pavesi, Lorenzo; Preti, Pietro; Piolini, Marco; Bertolini, Francesco; Robustelli Della Cuna, Gioacchino.

In: Anticancer Research, Vol. 16, No. 4 A, 07.1996, p. 1781-1785.

Research output: Contribution to journalArticle

@article{5b4088e105cc4c0c8e98646626e3e742,
title = "Effects of glycosylated and non-glycosylated G-CSFs, alone and in combination with other cytokines, on the growth of human progenitor cells",
abstract = "Two recombinant human granulocyte colony-stimulating factors (rHu G-CSF) are clinically available, a glycosylated (lenograstim) and a nonglycosylated form (filgrastim). Since there is accumulating evidence that glycosylation plays a role in the vitro activity of the G-CSF molecule, we compared the biological potency of lenograstim and filgrastim on human hematopietic progenitor cells by colony assay in semisolid medium and ex vivo expansion experiments. Leukapheretic products without further processing and CD34-positive purified cells were used as source of human progenitors. Lenograstim demonstrated greater capacity, to stimulate the colony growth of both, purified and CD34+ peripheral blood cells. This effects, which is evident especially at low doses of growth factor, seems not to be mediated by accessory cells. Whether these observations may have clinical relevance is still to be clearly assessed and further investigations are needed.",
keywords = "Hematopoietic progenitor cells, Recombinant human G-CSF",
author = "Paolo Pedrazzoli and Nadia Gibelli and Lorenzo Pavesi and Pietro Preti and Marco Piolini and Francesco Bertolini and {Robustelli Della Cuna}, Gioacchino",
year = "1996",
month = "7",
language = "English",
volume = "16",
pages = "1781--1785",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "4 A",

}

TY - JOUR

T1 - Effects of glycosylated and non-glycosylated G-CSFs, alone and in combination with other cytokines, on the growth of human progenitor cells

AU - Pedrazzoli, Paolo

AU - Gibelli, Nadia

AU - Pavesi, Lorenzo

AU - Preti, Pietro

AU - Piolini, Marco

AU - Bertolini, Francesco

AU - Robustelli Della Cuna, Gioacchino

PY - 1996/7

Y1 - 1996/7

N2 - Two recombinant human granulocyte colony-stimulating factors (rHu G-CSF) are clinically available, a glycosylated (lenograstim) and a nonglycosylated form (filgrastim). Since there is accumulating evidence that glycosylation plays a role in the vitro activity of the G-CSF molecule, we compared the biological potency of lenograstim and filgrastim on human hematopietic progenitor cells by colony assay in semisolid medium and ex vivo expansion experiments. Leukapheretic products without further processing and CD34-positive purified cells were used as source of human progenitors. Lenograstim demonstrated greater capacity, to stimulate the colony growth of both, purified and CD34+ peripheral blood cells. This effects, which is evident especially at low doses of growth factor, seems not to be mediated by accessory cells. Whether these observations may have clinical relevance is still to be clearly assessed and further investigations are needed.

AB - Two recombinant human granulocyte colony-stimulating factors (rHu G-CSF) are clinically available, a glycosylated (lenograstim) and a nonglycosylated form (filgrastim). Since there is accumulating evidence that glycosylation plays a role in the vitro activity of the G-CSF molecule, we compared the biological potency of lenograstim and filgrastim on human hematopietic progenitor cells by colony assay in semisolid medium and ex vivo expansion experiments. Leukapheretic products without further processing and CD34-positive purified cells were used as source of human progenitors. Lenograstim demonstrated greater capacity, to stimulate the colony growth of both, purified and CD34+ peripheral blood cells. This effects, which is evident especially at low doses of growth factor, seems not to be mediated by accessory cells. Whether these observations may have clinical relevance is still to be clearly assessed and further investigations are needed.

KW - Hematopoietic progenitor cells

KW - Recombinant human G-CSF

UR - http://www.scopus.com/inward/record.url?scp=0029759836&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029759836&partnerID=8YFLogxK

M3 - Article

C2 - 8712701

AN - SCOPUS:0029759836

VL - 16

SP - 1781

EP - 1785

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 4 A

ER -